Free Trial

Denali Therapeutics (DNLI) SEC Filings & 10K Form

Denali Therapeutics logo
$11.81 +0.21 (+1.78%)
As of 11:48 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Denali Therapeutics SEC Filings

DateFilerForm TypeView
04/02/2025
7:02 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
4:26 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:11 PM
Denali Therapeutics (Filer)
Form S-3ASR
02/27/2025
3:12 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:13 PM
Denali Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2025
1:14 PM
Capital Research Global Investors (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
9:52 AM
BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
Form SCHEDULE 13G/A
01/13/2025
7:03 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
7:23 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:24 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:25 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
7:26 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:01 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:03 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:06 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:08 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:10 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:12 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
7:14 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
5:56 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:57 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
5:59 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:17 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:18 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:44 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:19 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
8:55 AM
Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:39 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
3:30 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
10/18/2024
3:19 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
3:37 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:25 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2024
3:25 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
5:26 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:14 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:14 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:15 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:16 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
3:40 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This almost killed Elon Musk (chilling details emerge) (Ad)

Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.

See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro
08/21/2024
3:42 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:08 PM
Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:09 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
3:27 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
12:18 PM
Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
08/15/2024
3:10 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
7:36 PM
Denali Therapeutics (Subject)
Ho Carole (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
7:37 PM
Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
5:52 AM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
5:48 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2024
8:13 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
8:13 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:38 PM
Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
3:43 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
7:06 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:31 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:32 PM
Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:33 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:20 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:27 PM
Denali Therapeutics (Issuer)
Harris Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:28 PM
Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:29 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:30 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
5:30 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
3:01 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
4:14 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:32 PM
Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:DNLI) was last updated on 4/8/2025 by MarketBeat.com Staff
From Our Partners